Fritextsökning
Innehållstyper
-
Norwegian describes scrapie gene
Intestinal lymphatic tissue is important for the absorption and spread of the scrapie prion, suggests a Norwegian researcher.
-
Travelling scholarship to DTU professor
The Vera og Carl Johan Michaelsens Rejselegat has the founder of the Medicine and Technology program at DTU with a scholarship.
-
Nya vd:n stuvar om i toppen
Martin Mackay, FoU-chef på Astrazeneca, får gå efter omorganisation i ledningsgruppen.
-
Cancerskydd påverkas av gener
Folsyratillskott skyddar många kvinnor mot bröstcancer men för vissa ökar risken, visar ny forskning.
-
Pfizer höjer budet på Astrazeneca
Pfizer beskriver det nya budet, på 607 kronor aktien, som det "sista", men räknar inte med att Astrazenecas styrelse kommer att acceptera erbjudandet.
-
Budar på Sobi
Läkemedelsbolaget mottog nyligen ett bud från en ospecificerad budgivare.
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Future drugs from Amaryllis
A Danish research team has discovered possibolities to extract drugs fro Amaryllis.
-
Forskare får hjälp att fatta beslut
En ny mjukvara ska samla in och tolka resultat från kliniska prövningar.
-
Thomas Lönngren till NDA
Thomas Lönngren, tidigare chef för European Medicines Agency (EMA) slår sig ihop med konsultfirman NDA med målet att snabbare få ut fler läkemedel på marknaden.
-
Glucose facilitates the use of indigo
The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.
-
Hey Johannes Hedman...
... graduate of SKL and LTH, who has improved a method of forensic analysis
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
New CEO to Medivir
The Board of the Swedish biotech company Medivir has appointed the successor to the current CEO Lars Adlersson.
-
Studie: Önsketänkande kan ha väglett beteende under pandemin
En ny doktorsavhandling tyder på att vi systematiskt underskattar hälsorisker – om och när det passar oss. Det gällde inte minst under pandemin då våra riskbedö...
-
Bio engineering breakthrough in Denmark
Brand new research makes BioGasol's cellulosic ethanol process even more competitive.
-
Norwegian entrance in EU technology network
The Norwegian University of Science and Technology joins the European Science Business Network of prominent European research institutions.
-
New faces in Pronova Biopharma team
The Norwegian company Pronova Biopharma has recently changed the management team structure.
-
Medicult acquires embryo scanner
The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.
-
We are poor lobbyists
I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
New influenza vaccine to EU
The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.
-
Stockholm-Uppsala life science cluster in brief
Stockholm-Uppsala evolves around the research at Karolinska Institutet and Uppsala University. Typical areas of research are protein research, neuroscience and cancer.
BREAKING